Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials.
Jonathan Ian SilverbergMark BoguniewiczJon HanifinKim A PappHaixin ZhangAna Beatris RossiNoah A LevitPublished in: Dermatology and therapy (2022)
LIBERTY AD SOLO 1: NCT02277743; LIBERTY AD SOLO 2: NCT02277769. Infographic available for this article.